Although IL-10 is known to be an important cytokine in the immune response to TB, very little is known about the role of IL-20 subfamily of cytokines in the host response to TB. 
Introduction
IL-10 is an immunosuppressive cytokine crucial for dampening the immune response and limiting host immune pathology to numerous intracellular pathogens, including Mycobacterium tuberculosis (Mtb) [1] . Thus, during acute infections, IL-10 is crucial in limiting host tissue damage as a consequence of excessive inflammation [2, 3] . IL-10 is a regulatory cytokine that inhibits cytokine production and proliferation of CD4 + T cells and APC function [4, 5] . IL-10 directly affects the function of T cells and inhibits IL-2, TNF, and IL-5 production depending on activation conditions [6, 7] . IL-10 is produced by almost all innate and adaptive immune cells, including B cells, dendritic cells, macrophages, CD4 + , and CD8 + T cells [2, 8] . However, recent reports confirm that effector CD4 + T cell production from IL-10 plays an important role in limiting host pathology and fostering chronicity of infection [9] . Effector function in CD4 + T cells is mainly facilitated by Th1, Th2 and Th17 cytokines [10] . In addition, regulatory T cells, are also known to be key producers of IL-10 in immunity to infections [11] . IL-20 subfamily of cytokines comprises IL-19, IL-20, IL-22, IL-24 and IL-26, these cytokines are members of larger IL-10 family of cytokines, all together they are grouped to form the IL-20 subfamily based on their usage of common receptor subunit [8] . IL-10 shares the receptor complexes of IL-10R1/IL-10R2, whereas IL-19 and IL-24 share common receptor complexes of IL-20R1/IL-20R2 heterodimer [12, 13] . The regulated expression pattern of their receptors drives the unique biology of IL-20 subfamily cytokines and distinguishes them from other IL-10 family members [8, 13] . These IL-20 subfamily cytokines contribute to tissue healing processes in injury or infection and promote innate immune responses to limit damage associated with viral and bacterial infections [1, 8] . IL-20 subfamily cytokines are largely produced by leukocytes and act on epithelial tissues to augment epithelial innate immunity [8] . IL-20 subfamily cytokines are chiefly produced by immune cells, such as myeloid cells and lymphocyte and T cells are the primary cellular source of IL-20 subfamily of cytokines including IL-22, IL-24 and IL-26. Although, IL-10 plays a substantial role in the immune response to TB, the role of the IL-20 subfamily of cytokines is still not completely clear in TB infection and disease. By using flow cytometry to examine the expression pattern of IL-10, IL-19 and IL-24 in T cells of active pulmonary TB (PTB) and latent TB (LTB) individuals, we determine that PTB is associated with expanded IL-10, IL-19 and IL-24 expressing  CD4  + and CD8  + helper T cell subsets following Mtb-specific antigen stimulation. Finally, we show that IL-10, IL-19 and IL-24 can each down modulate the Th1/Tc1 and/or Th17/Tc17 cytokine profile of TB antigen stimulated CD4 + and CD8 + T cells.
Materials and methods

Ethics statement
This study was approved by the Internal Ethics Committee of the National Institutes for Research in Tuberculosis. Chennai, India (NIRT IRB No. 2010002) Informed written consent was obtained from all participants. All the methods were performed in accordance with the relevant Internal Ethics Committee guidelines
Study population
We studied a group of 30 individuals with pulmonary TB (PTB) and 30 individuals with latent TB (LTB) ( Table 1) . Individuals with pulmonary TB were diagnosed by positive solid cultures in Lowenstein-Jensen medium. Smear grades were determined by sputum microscopy and culture was graded as 0, 1+, 2+, and 3+ with zero being no bacteria in microscopy and 3+ the highest number of bacteria. The extent of chest disease was assessed by Chest X-ray and was classified as unilateral or bilateral disease for the purposes of this study. Individuals were diagnosed as having LTB on the basis of being positive in the Quantiferon-TB Gold in Tube (Cellestis) assay but having an absence of pulmonary symptoms concurrent with a normal chest radiograph. The two groups of individuals were age and sex matched. All subjects had been bacillus Calmette-Guerin (BCG) vaccinated at birth. All the individuals were HIV negative, not diabetic or suffering from autoimmune disorders and blood was collected prior to commencement of anti-TB treatment.
Antigens
Mycobacterial antigens-PPD (Statens Serum Institute, Copenhagen, Denmark), ESAT-6 and CFP-10 (both from NIAID TB antigen repository at BEI resources) were used as antigenic stimuli, and anti-CD3 antibody was used as positive control. Final concentrations were 10 ug/ml for PPD, ESAT-6 and CFP-10, and 5 ug/ml for anti-CD3.
In vitro culture
Whole blood cell cultures were performed to determine the in vitro responses to antigens. Briefly, whole blood was diluted 1:1 with RPMI1640 medium supplemented with penicillin/streptomycin (100 U/100 ug/ml), L-glutamine (2 uM), and HEPES (10 uM; all from Invitrogen) and distributed in 12-well tissue culture plates (Costar). The cultures were then stimulated with PPD, ESAT-6+CFP-10, or anti-CD3 or with medium alone in the presence of CD49d/CD28 at 37°C for 18 h. Brefeldin A (10 ug/mL) was added after 12 h. After 18 h, centrifugation, washing, and red blood cell lysis was performed. The cells were fixed using cytofix/cytoperm buffer (BD Biosciences, San Jose, CA) and stored at 80°C. For neutralization experiments, whole blood was cultured in the presence of anti-IL-10 (5 ug/ml), anti-IL-19 (5 ug/ml) and anti-IL-24 (5 ug/ml) (R&D Systems, Minneapolis, MN), at 37°C for 6 h following which PPD was added and Brefeldin A (10 ug/ml) was added after 1 h. The cells were then cultured for a further 16 h.
Intracellular cytokine staining
The cells were thawed, washed with cold PBS and permeabilized with 1x permeabilization buffer (Foxp3 staining buffer from eBiosciences). Cells were then stained with surface antibodies for 30 
Statistical analysis
Geometric mean was used as the measure of central tendency. Comparisons were made using either the Mann-Whitney test (unpaired comparisons) or the Wilcoxon signed rank test (paired comparisons). All statistics were performed using GraphPad Prism version 6 for Windows (GraphPad Software, Inc.). [190] [191] [192] [193] [194] [195] [196] either mycobacterial antigens or anti-CD3 ( 
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not Tc17 and Tc2 cells.
IL-10, IL-19 and IL-24 do not regulate the antigen-stimulated frequencies of Th1 and Th17 cells in LTB
We sought to determine the role of IL-10, IL-19 and IL-24 in regulating Th1, Th2 and Th17 cytokines in LTB. Thus, we stimulated whole blood from a subset of LTB individuals (n = 10) with PPD in the presence of neutralizing antibodies to IL-10 or IL-19 or IL-24 and measured the frequencies of Th1 (IFNγ, IL-2 and TNFα), Th2 (IL-4, IL-5 and IL-13) and Th17 (IL-17A, IL-17F and IL-22) cells (Fig. 5) . As shown in Fig. 5 , blockade of IL-10 ( Fig. 5a), IL-19 (Fig. 5b) and IL-24 ( Fig. 5c ) resulted in no significant alteration in the frequencies of PPD-stimulated Th1, Th2 and Th17 cells.
IL-10, IL-19 and IL-24 do not regulate the antigen-stimulated frequencies of Tc1 and Tc17 cells in LTB
We sought to determine the role of IL-10, IL-19 and IL-24 in regulating Tc1, Tc2 and Tc17 cytokines in LTB. Thus, we stimulated whole blood from a subset of LTB individuals (n = 10) with PPD in the presence of neutralizing antibodies to IL-10 or IL-19 or IL-24 and measured the frequencies of Tc1 (IFNγ, IL-2 and TNFα), Tc2 (IL-4, IL-5 and IL-13) and Tc17 (IL-17A, IL-17F and IL-22) cells (Fig. 6 ). As shown in Fig. 6 , blockade of IL-10 ( Fig. 6a), IL-19 (Fig. 6b) and IL-24 ( Fig. 6c) resulted in no significant alteration in the frequencies of PPD-stimulated Tc1, Tc2 and Tc17 cells.
Discussion
The role of the IL-20 subfamily of cytokines is still not completely understood in the context of tuberculosis disease. Predominantly, IL-20 subfamily of cytokines acts on numerous epithelial cells and protect the cells from invasion by extracellular pathogens such as bacteria and yeast. IL-20 subfamily cytokines and IL-10 also prevent tissue damage caused by infections and inflammation [1] . IL-10, on the other hand, controls and represses the expression of pro-inflammatory cytokines during the recovery phase of infections and reduces the tissue damage caused by these cytokines [2, 14] . In addition, these cytokines boost tissue remodelling and wound-healing activities, which help to maintain tissue integrity and restore homeostasis of epithelial layers during infection and inflammatory responses [15, 16] . It has been proposed that IL-20 subfamily members have similar function in the protection of epithelial tissue against viral and bacterial infections, respectively [17] . But, how these alterations impact the immune response to infections or bystander antigens remains unclear. We have previously shown that systemic levels IL-20 subfamily of cytokines like IL-19, IL-20 and IL-24 were significantly increased in PTB and LTB individuals compare to PTB and LTB individuals with coincident diabetes mellitus [18] and we also reported that PTB is associated with expanded IL-10 expression by CD4 + helper T cell subsets following TB antigen stimulation [19] . Thus, IL-10 might play a main role in promoting susceptibility to TB disease by altering the cytokine milieu. Therefore, we examined the association of IL-20 subfamily of cytokines in TB infection and disease. IL-10 plays a very vital role in the regulation of host immune response against Mtb infection [20] . IL-10 impedes the protective immune response to pathogens by blocking the production of proinflammatory cytokines, such as TNFα and the Th1-polarizing cytokine IL-12, by directly acting on antigen-presenting cells such as macrophages and dendritic cell (DC) [21, 22] . IL-10 is also known to cause inhibition of macrophage effector functions, with reduced bacterial killing and diminished cytokine/chemokine secretion [23, 24] , block the chemotactic factors that control DC trafficking to the lymph nodes [24] , inhibit the differentiation of naive CD4 + T cells to Th1 cells [25] and finally suppress Th1, Th2, and Th17 cytokine production [26, 27] . Although IL-10 production from myeloid cells is documented, T cells are also the major source of IL-10 in a variety of infections including tuberculosis [9] . Previous published human TB studies report that IL-10 levels were significantly elevated in the lungs [28] and serum [29] of active pulmonary TB patients. Subsequently, it is also reported that IL-10 levels are significantly increased in individuals with active TB and a higher capacity to produce IL-10 is associated with an increase in the disease incidence [20] . In addition, we have previously reported that upon TB antigen stimulus, IL-10 expressing Th1 (IFNγ), Th2 (IL-4) and Th17 (IL-17A) cytokines were significantly enhanced in PTB compared to LTB individuals [19] . In agreement with these reports, our data also show that IL-10 exhibits increased levels in PTB compared to LTB upon TB antigen stimulation. Since IL-10 is known to be a key cytokine in the immune response to TB [20] , it is not surprising to find that CD4 + and CD8 + T cell subsets exhibit the ability to produce IL-10. In addition, our data report that neutralization of IL-10 resulted in the enhanced frequencies of CD4 + and CD8 + T cell subsets expressing Th1/Tc1 and Th17/Tc17 cytokines in only PTB individuals but not in the LTB individuals indicating that altered cytokines responses are seen only in the active disease state but not in the latent TB infection. Our study, therefore, confirms an important role for Th1 cells in the pathogenesis of tuberculosis and suggests that heightened frequencies of Th1 cytokines might actually reflect an increased severity of disease or may reflect a higher antigen load [30] . Traditionally, IL-10 from T cells was shown to be mainly produced by the Th2 subsets, however in our study we didn't see any alterations in Th2 cytokines upon IL-10 neutralisation. Our data on the examination of Th17 cytokines reveal that increased frequencies of IL-17A but not IL-17F or IL-22, in patients with tuberculosis upon IL-10 neutralisation. Previous published studies have reported that IL-17A plays an important role for responses to the fungal pathogen, Candida albicans, whereas Th17 cells co-expressing IL-17A and IL-10 are important for responses to the bacterial pathogen, Staphylococcus aureus [31] . Collectively, previously published studies [32, 33] and our data confirm that IL-10 functions to limit the immune response to Mtb and may contribute to TB pathogenesis. IL-19 has been shown to increase Th2 cytokine expression in activated T cells and activated monocytes and its expression has been shown to be increased in certain Th2-mediated diseases such as atopic dermatitis and asthma [15, 16, 34] . IL-24 is specially expressed by Th2 cells [35] but it is unknown how IL-24 expression in regulated by Th2 cells. Apparently, transcription factors that drive the expression of other Th2-cytokines such as STAT6 and GATA3 are also involved in the regulation of IL-24 [36] . IL-24, has been implicated to play an important role in host defence against tumours [36] . Previous published data from mouse model of S. aureus, however, clearly reveals a vital immuno-modulatory role for IL-19 and IL-24 in suppressing IL-1β and IL-17 dependent effector pathways and promoting susceptibility to infection [34] . Similar to our finding from PTB patients, studies from helminth infections reported an expansion in CD4 + T cells expressing IL-19 and IL-24 levels compared to the uninfected group [37] . Subsequently another helminth study reported that upon IL-10, IL-19 and IL-24 neutralisation resulted in increased CD4 + Th1, Th2 and Th17 and CD8 + Tc1, Tc2 and Tc17 cytokines [38] . Published data from our lab also reports that systemic levels of IL-19 and IL-24 were significantly enhanced in PTB and LTB individuals compared to PTB or LTB individuals with coincident diabetes mellitus [18] . Thus, existing results indicates that IL-20 subfamily of cytokines resemble IL-10 in functioning as down modulatory or regulatory cytokines in dampening inflammatory response during chronic inflammation which in turn may contribute to amelioration of TB pathology. In this study, we provide complete evidence for the regulatory role for the two of the IL-20 subfamily of cytokines, IL-19 and IL-24. Our findings confirm the potent role played by IL-10 in TB infection by determining its effect on both CD4 + and CD8 + T cells responding to TB antigen. Thus, IL-10 clearly down-modulates the Th1/Tc1 and Th17/ Tc17 cytokines of T cell subsets responding to TB antigens. We consistently detected a significantly higher proportion of CD4 + and CD8 elucidate the factors regulating T cell subsets. Our data clearly highlight an important role for IL-20 subfamily cytokines in response to M. tuberculosis infection but also in the modulation of cell responses in tuberculous disease. To our knowledge, this is the first study describing the novel role of the cytokines -IL-19 and IL-24 in modulating T cell function in TB disease.
